Piper Sandler analyst Edward Tenthoff reiterates Mesoblast (NASDAQ:MESO) with a Overweight and ra

Mesoblast (NASDAQ:MESO) reported quarterly losses of $(0.04) per share which missed the analyst cons

Mesoblast Limited (MESO) Q4 2026 Earnings Call Transcript

RYONCIL Market Share Expands; Phase 3 Back Pain Trial Completes Treatment Financial Results and Oper

Mesoblast NASDAQ: MESO reported $115 million in net revenue for fiscal 2026, its first full year of

Mesoblast (NASDAQ:MESO) released full-year financial results and hosted an earnings call on Wednesda

US stock futures rise, Dow up 150 points. Flowers Foods (NYSE:FLO) plunges on poor earnings & lo

Mesoblast rises after completing treatment of 350 patients in a pivotal phase III study of rexlemest

Mesoblast Limited (NASDAQ:MESO) stock is trading higher on Monday after the company concluded patien

Mesoblast finished patient dosing in its Phase 3 trial for a cellular back pain treatment, targeting

H World Group (HTHT) beats earnings and raises sales guidance, shares jump 8.1%. Other big gainers i

NEW YORK, Aug. 16, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader

U.S. stock futures mixed, Dow down 0.1%. Swarmer Inc (NASDAQ: SWMR) shares drop 7% after reporting w

Expanding indications for RYONCIL in children and adults with life-threatening inflammatory diseases

Does Mesoblast Limited (MESO) have what it takes to be a top stock pick for momentum investors? Let'

US stocks close higher, Dow Jones up 100 points, PayPal shares rise on $53 billion acquisition propo

NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader

Mesoblast transitions to a commercial-stage company, anchored by FDA-approved Ryoncil and robust ear

NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

U.S. stock futures down, Nasdaq 100 futures drop over 1%. ON Semi to acquire Synaptics, ON shares fa

Optimized capital structure, retiring short-term maturing debt Well-funded for commercial operations

Achieved Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Activity Repo

NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader

Stock News JPMorgan tops Q1 estimates: JPMorgan Chase (JPM) posted Q1 EPS of $5.94 on revenue of $50

Mesoblast Limited (NASDAQ: MESO - Get Free Report) Director Gregory George bought 1,981,890 shares o

Mesoblast Limited (NASDAQ: MESO - Get Free Report) Director Gregory George acquired 4,000,000 shares

U.S. stock futures down, Nasdaq 100 falls over 100 points. Mach Natural Resources LP (MNR) shares di

SILO stock rose 51.8% in pre-market trading after its PTSD treatment pipeline received a patent from

Mesoblast (NASDAQ:MESO) reported quarterly losses of $(0.03) per share which beat the analyst consen

Mesoblast shares fall after new Ryoncil data show high survival in severe GVHD. Company plans adult

Mesoblast reports early real-world data showing 84% survival in children treated with FDA-approved R

Mesoblast says FDA feedback supports filing plans for its cell therapy to treat chronic back pain, s

Mesoblast reported strong year‑over‑year growth in December quarter sales of its flagship therapy, R

Revenue from cell therapy products was US$20.6 million, up from US$12.9 million in the previous quar